Last reviewed · How we verify
NCT05817721: PROTOCOL
PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents
trial testing Proton pump inhibitor in Acute Pancreatitis in 893 participants. Completed in 29 March 2024.
29 March 2024
Quick facts
| Lead sponsor | University Medical Center Goettingen |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 893 |
| Start date | 5 May 2023 |
| Primary completion | 29 March 2024 |
| Estimated completion | 29 March 2024 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Proton pump inhibitor — full drug profile →
- LAMS-implantation
Conditions studied
- Acute Pancreatitis — all drugs for Acute Pancreatitis →
Sponsor
University Medical Center Goettingen
Who can join
18 and older, any sex, with Acute Pancreatitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational retrospective cohort study in combination with an expert study is to assess the clinical relevance and management of Lumen apposing metal stent (LAMS)-occlusion and LAMS-occlusion-related complications as well as the influence of proton pump inhibitors (PPI) on LAMS-occlusion. The main questions this study aims to answer are: * the individual management of LAMS-occlusion and LAMS-occlusion-related complications in the respective centers participating in the study. * if there is an association between PPI-intake and LAMS-occlusion and endoscopic necrosectomies. Participants for the retrospective cohort study will be enrolled retrospectively among European centers with expertise in pancreatology. The expert survey will be distributed European-wide to centers with special expertise in pancreatology.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05817721
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Proton pump inhibitor
Trials testing the same drug.
- NCT05533619 — Risk Factors and Machine Learning Model for Proton Pump Inhibitor Related Acute Kidney Injury · completed
- NCT04415983 — Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children · Phase 3 · recruiting
- NCT05688761 — Nordic Gastric and Esophageal Tumor Study · completed
- NCT05974410 — Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients · available
Other recruiting trials for Acute Pancreatitis
Currently open trials in the same condition.
- NCT07464392 — FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis · NA · recruiting
- NCT06899087 — DEciphering CIrculating SIgnatures Of Infected Pancreatic Necrosis · recruiting
- NCT07322978 — Incidence of Splanchnic Venous Thrombosis in Acute Pancreatitis and it's Correlation With Severity of Pancreatitis · recruiting
- NCT03547232 — Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial) · Phase 4 · recruiting
- NCT06401577 — Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics · recruiting
Other University Medical Center Goettingen trials
Trials by the same sponsor.
- NCT07505498 — Screening for Supportive Care Needs of Oncological Patients and Professionals - Evaluation of a Short PRO-question Set · recruiting
- NCT07008677 — Oral Health Awareness and Status Among Professional Musicians in German Orchestras · completed
- NCT07529041 — Real-time Acoustic Biofeedback for Enhancing Fixation Stability: A Proof-of-concept Study to Improve Ophthalmic Imaging · NA · enrolling by invitation
- NCT06921863 — This Study Aims to Quantify Decisional Regret as Well as Quality of Life in Patients With Low- to High-risk Cancer and H · not yet recruiting
- NCT07476365 — A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05817721 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medical Center Goettingen
- Last refreshed: 15 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05817721.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing